eMedicine Specialties > Dermatology > Lymphoma and Related Processes
Pseudolymphoma, Cutaneous: Multimedia
Updated: Oct 22, 2008
Multimedia
![]() | Media file 1: This localized example of pseudolymphoma shows an ill-defined, thin, erythematous plaque. |
![]() | Media file 2: Pseudolymphomatous drug eruption due to captopril, marked by erythematous to purple papules, patches, and plaques. |
![]() | Media file 3: This erythrodermic pseudolymphoma (T-cell pattern) typifies drug-induced pseudolymphoma, which is most often secondary to anticonvulsant therapy. |
![]() | Media file 4: Biopsy specimens of pseudolymphoma vary substantially, but they most often exhibit a mixed inflammatory infiltrate with prominent lymphoid follicle formation. |
More on Pseudolymphoma, Cutaneous |
| Overview: Pseudolymphoma, Cutaneous |
| Differential Diagnoses & Workup: Pseudolymphoma, Cutaneous |
| Treatment & Medication: Pseudolymphoma, Cutaneous |
| Follow-up: Pseudolymphoma, Cutaneous |
Multimedia: Pseudolymphoma, Cutaneous |
| References |
| « Previous Page |
References
Brodell RT, Santa Cruz DJ. Cutaneous pseudolymphomas. Dermatol Clin. Oct 1985;3(4):719-34. [Medline].
Choi TS, Doh KS, Kim SH, Jang MS, Suh KS, Kim ST. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol. Apr 2003;148(4):730-6. [Medline].
Albrecht J, Fine LA, Piette W. Drug-associated lymphoma and pseudolymphoma: recognition and management. Dermatol Clin. Apr 2007;25(2):233-44, vii. [Medline].
Maubec E, Pinquier L, Viguier M, Caux F, Amsler E, Aractingi S, et al. Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol. Apr 2005;52(4):623-9. [Medline].
Braun RP, French LE, Feldmann R, Chavaz P, Saurat JH. Cutaneous pseudolymphoma, lymphomatoid contact dermatitis type, as an unusual cause of symmetrical upper eyelid nodules. Br J Dermatol. Aug 2000;143(2):411-4. [Medline].
Gutermuth J, Audring H, Roseeuw D. Disseminated cutaneous B-cell lymphoma mimicking pseudolymphoma over a period of six years. Am J Dermatopathol. Jun 2004;26(3):225-9. [Medline].
Kempf W, Dummer R, Burg G. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Am J Clin Pathol. Jan 1999;111(1 Suppl 1):S84-93. [Medline].
Burg G, Kerl H, Schmoeckel C. Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol. Apr 1984;10(4):271-5. [Medline].
Geerts ML, Kaiserling E. A morphologic study of lymphadenosis benigna cutis. Dermatologica. 1985;170(3):121-7. [Medline].
Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. Jun 1998;38(6 Pt 1):877-95; quiz 896-7. [Medline].
Connors RC, Ackerman AB. Histologic pseudomalignancies of the skin. Arch Dermatol. Dec 1976;112(12):1767-80. [Medline].
Rijlaarsdam U, Willemze R. Cutaneous pseudo-T-cell lymphomas. Semin Diagn Pathol. May 1991;8(2):102-8. [Medline].
Further Reading
Keywords
lymphocytoma cutis, cutaneous lymphomatous hyperplasia, lymphadenosis benigna cutis, cutaneous lymphoplasia








Multimedia: Pseudolymphoma, Cutaneous